Initiation of a phase 1 dose-escalating study of weekly direct-to-brain administration of solubilised formulation of panobinostat (MTX110) in patients with recurrent glioblastoma (MAGIC-G1 study)

lomustine - Generic mfg.

panobinostat (MTX110) - Midatech

Farydak (panobinostat) - Secura Bio

Annick Desjardins, MD, FRCPC; Kelly Conlon, PhD; Hannah Gunning; Rhian Davies, BSc; Jordan Komisarow; Robert Cavaliere, MD; Dmitry Zamoryakhin

Sep 28, 2022